Express News | Barclays Maintains Equal-Weight on Kimberly-Clark, Lowers Price Target to $135
Market Chatter: Kimberly-Clark Finalizes 3 Bidders for Sale of International Tissue Business
A Quick Look at Today's Ratings for Kimberly-Clark(KMB.US), With a Forecast Between $144 to $162
Kimberly-Clark's $4 Billion International Tissue Unit Set for Three-way M&A Fight, Sources Say
Express News | A Sale Could Value the International Tissue Unit at Around $4 Billion, Sources Say
Express News | Royal Golden Eagle, Asia Pulp & Paper and Suzano Are Final Bidders for Kimberly-Clark's International Tissue Unit, Sources Say
Kimberly-Clark Analysts Slash Their Forecasts Following Weak Sales
Express News | RBC Capital Maintains Outperform on Kimberly-Clark, Lowers Price Target to $162
Kimberly-Clark Is Maintained at Overweight by Piper Sandler
Barclays Adjusts Price Target on Kimberly-Clark to $135 From $139, Maintains Equalweight Rating
Kimberly-Clark Price Target Cut to $155.00/Share From $168.00 by Evercore ISI Group
Kimberly-Clark Analyst Ratings
Goldman Sachs Adjusts Price Target on Kimberly-Clark to $146 From $151, Maintains Buy Rating
Evercore ISI Adjusts Price Target on Kimberly-Clark to $155 From $168, Maintains Outperform Rating
BNP Paribas Exane Adjusts Price Target on Kimberly-Clark to $139 From $144, Maintains Neutral Rating
Deutsche Bank Adjusts Kimberly-Clark Price Target to $138 From $140, Maintains Hold Rating
Express News | Kimberly-Clark Corp : JP Morgan Cuts Target Price to $126 From $131
Kimberly-Clark Reports Q1 2025 Results Amid Challenges
Research Alert: CFRA Reaffirms Hold View On Shares Of Kimberly-clark Corporation
Kimberly-Clark | 10-Q: Q1 2025 Earnings Report